Prevention of vasoplegia with CytoSorb in heart failure patients undergoing cardiac surgery (CytoSorb-HF trial): protocol for a randomised controlled trial

INTRODUCTION: Vasoplegia is a common complication after cardiac surgery and is associated with poor prognosis. It is characterised by refractory hypotension despite normal or even increased cardiac output. The pathophysiology is complex and includes the systemic inflammatory response caused by cardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Papazisi, Olga, Bruggemans, Eline F, Berendsen, Remco R, Hugo, Juan D V, Lindeman, Jan H N, Beeres, Saskia L M A, Arbous, M Sesmu, van den Hout, Wilbert B, Mertens, Bart J A, Ince, Can, Klautz, Robert J M, Palmen, Meindert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486306/
https://www.ncbi.nlm.nih.gov/pubmed/36123067
http://dx.doi.org/10.1136/bmjopen-2022-061337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486306/
https://www.ncbi.nlm.nih.gov/pubmed/36123067
http://dx.doi.org/10.1136/bmjopen-2022-061337

Ejemplares similares